RYAN BROGAN: Open Payments
NPI 1518476498 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 49 payments from 14 companies in 2025. Trend: 2023 $1,137 · 2024 $1,248 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $207 |
| Novo Nordisk Inc | 7 | $143 |
| E.R. Squibb & Sons, L.L.C. | 9 | $139 |
| Novartis Pharmaceuticals Corporation | 7 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Alnylam Pharmaceuticals Inc. | 2 | $50 |
| Amgen Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: CAMZYOS, Wegovy, JARDIANCE, LEQVIO, AIRSUPRA, FARXIGA, Kerendia, ONPATTRO.
Industry payments across MA — which companies pay providers there.
